Phil King’s Regal writes Opthea to zero and backs off risky bets
The veteran stockpicker told investors the firm would review how its $220 million wager on the biotech went so wrong “to ...
Health Check: FDA casualties mount as Trump’s ‘revolution’ takes place
Grisly tales are emerging from the corridors of the US Food & Drug Administration (FDA) as mass sackings  take effect.